Posted: Oct 25, 2013 8:50 AM by Associated Press
Updated: Oct 25, 2013 9:18 AM
WASHINGTON (AP) - The Food and Drug Administration has approved a radioactive imaging chemical from General Electric to help screen for Alzheimer's disease.
The drug, Vizamyl, is an injection of radioactive material designed to highlight abnormal brain plaque in medical imaging scans.
Dementia caused by Alzheimer's is associated with buildup of the plaque, known as beta amyloid protein. However, it can also be found in patients who do not have neurological problems.
Vizamyl works by binding to the plaque and creating images that show up on positron emission tomography, or PET, scans of the brain.
The FDA says a negative scan means there is little plaque and the cause of dementia is probably not Alzheimer's. A positive scan means the patient has at least some plaque, but does not prove they have Alzheimer's.
Click here to submit a news tip to us!
Become a Facebook Fan!
Help those in need this holiday season
Win! Win! Win!
Wise Local Marketing!
Get news, weather and more on your smartphone and tablet!
Get texts for news, traffic, deals and more!
Sign up on KVOA.com for newsletters, exclusive deals, and more!
What's happening on News 4 @ 4
Stories and videos with Kristi's Kids
Check out the latest events FC Tucson has scheduled.
Let us help grow your business
Digital Channel 4.2
What's on KVOA and when!
Contact info for our department heads
KVOA's on air personalities!
Work at News 4 Tucson
Complete feeds of all KVOA.com stories
FCC Public File of Records, Reports, and More